CHARLOTTESVILLE, Va., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that may ...
This is a preview. Log in through your library . Abstract The inadequacy of our present conceptualization of the part played by channels of communication in the diffusion of innovations is explored.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback